[en] Background: Platelets have been involved in both surveillance and host defense against severe infection. To date, whether platelet phenotype or other hemostasis components could be associated with predisposition to sepsis in critical illness remains unknown. The aim of this work was to identify platelet markers that could predict sepsis occurrence in critically ill injured patients.
Results: This single-center, prospective, observational, 7-month study was based on a cohort of 99 non-infected adult patients admitted to ICUs for elective cardiac surgery, trauma, acute brain injury and post-operative prolonged ventilation and followed up during ICU stay. Clinical characteristics and severity score (SOFA) were recorded on admission. Platelet activation markers, including fibrinogen binding to platelets, platelet membrane P-selectin expression, plasma soluble CD40L, and platelet-leukocytes aggregates were assayed by flow cytometry at admission and 48h later, and also at the time of sepsis diagnosis (Sepsis-3 criteria) and 7 days later for sepsis patients. Hospitalization data and outcomes were also recorded. Of the 99 patients, 19 developed sepsis after a median time of 5 days. SOFA at admission was higher; their levels of fibrinogen binding to platelets (platelet-Fg) and of D-dimers were significantly increased compared to the other patients. Levels 48h after ICU admission were no longer significant. Platelet-Fg % was an independent predictor of sepsis (P = 0.030). By ROC curve analysis cutoff points for SOFA (AUC=0.85) and Platelet-Fg (AUC=0.75) were 8 and 50%, respectively. The prior risk of sepsis (19%) increased to 50% when SOFA was above 8, to 46% when Platelet-Fg was above 50%, and to 87% when both SOFA and Platelet-Fg were above their cutoff values. By contrast, when the two parameters were below their cutoffs, the risk of sepsis was negligible (3.8%). Patients with sepsis had longer ICU and hospital stays and higher death rate.
Conclusion: In addition to SOFA, platelet-bound fibrinogen levels assayed by flow cytometry within 24h of ICU admission help identifying critically ill patients at risk of developing sepsis.
Disciplines :
Immunology & infectious disease
Author, co-author :
LAYIOS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Service des soins intensifs généraux
Hego, Alexandre ; Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences
HUART, Justine ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs médecine - Pool assistants
GOSSET, Christian ; Centre Hospitalier Universitaire de Liège - CHU > Service d'hématologie biologique et immuno-hématologie
LECUT, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > Service d'hématologie biologique et immuno-hématologie
MAES, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Service des informations médico économiques (SIME)
Geurts, Pierre ; Université de Liège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Algorith. des syst. en interaction avec le monde physique
Joly, Arnaud ; Université de Liège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Systèmes et modélisation
LANCELLOTTI, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie
Albert, Adelin ; Université de Liège > Département des sciences de la santé publique > Département des sciences de la santé publique
DAMAS, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Service des soins intensifs généraux
GOTHOT, André ; Centre Hospitalier Universitaire de Liège - CHU > Service d'hématologie biologique et immuno-hématologie
Oury, Cécile ; Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences
Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840–851
Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260–268
Morrell CN, Aggrey AA, Chapman LM, Modjeski KL (2014) Emerging roles for platelets as immune and inflammatory cells. Blood 123:2759–2767
Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM et al (2007) Platelet tlr4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13:463–469
Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP et al (2006) Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107:637–641
Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264–274
Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM et al (1998) Signal-dependent translation of a regulatory protein, bcl-3, in activated human platelets. Proc Natl Acad Sci U S A 95:5556–5561
Thomas MR, Storey RF (2015) The role of platelets in inflammation. Thromb Haemost 114:449–458
Yeaman MR, Bayer AS, Koo SP, Foss W, Sullam PM (1998) Platelet microbicidal proteins and neutrophil defensin disrupt the staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 101:178–187
Yeaman MR, Tang YQ, Shen AJ, Bayer AS, Selsted ME (1997) Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 65:1023–1031
Kerrigan SW, Douglas I, Wray A, Heath J, Byrne MF, Fitzgerald D et al (2002) A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 100:509–516
Dankert J, van der Werff J, Zaat SA, Joldersma W, Klein D, Hess J (1995) Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 63:663–671
Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND et al (2011) Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog 7:e1002355
Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P (2013) Nucleation of platelets with blood-borne pathogens on kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 14:785–792
Dewitte A, Tanga A, Villeneuve J, Lepreux S, Ouattara A, Desmouliere A et al (2015) New frontiers for platelet cd154. Exp Hematol Oncol 4:6
de Stoppelaar SF, van 't Veer C, van der Poll T (2014) The role of platelets in sepsis. Thromb Haemost 112:666–677
Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E et al (2003) Injury primes the innate immune system for enhanced toll-like receptor reactivity. J Immunol 171:1473–1483
Boldt J, Menges T, Wollbruck M, Sonneborn S, Hempelmann G (1994) Platelet function in critically ill patients. Chest 106:899–903
De Blasi RA, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R (2013) Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med 39:636–643
Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y et al (2001) Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 50:801–809
Toh CH, Hoots WK, ISTH SSCoDICot (2007) The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: a 5-year overview. J Thromb Haemost 5:604–606
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810
Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG (2001) Platelet activation and function after trauma. J Trauma 51:639–647
Davies GR, Mills GM, Lawrence M, Battle C, Morris K, Hawkins K et al (2014) The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS One 9:e108589
Fateh-Moghadam S, Htun P, Tomandl B, Sander D, Stellos K, Geisler T et al (2007) Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost 97:974–978
Gielen CL, Brand A, van Heerde WL, Stijnen T, Klautz RJ, Eikenboom J (2016) Hemostatic alterations during coronary artery bypass grafting. Thromb Res 140:140–146
Li N, Astudillo R, Ivert T, Hjemdahl P (2003) Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery. J Thromb Haemost 1:470–476
Windelov NA, Ostrowski SR, Johansson PI, Wanscher M, Larsen CF, Sorensen AM et al (2015) Circulating levels of platelet alpha-granule cytokines in trauma patients. Inflamm Res 64:235–241
Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR et al (2009) Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res 124:213–218
Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M et al (2003) Nosocomial pneumonia after acute stroke: Implications for neurological intensive care medicine. Stroke 34:975–981
Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U (2005) Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6:775–786
Russwurm S, Vickers J, Meier-Hellmann A, Spangenberg P, Bredle D, Reinhart K et al (2002) Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 17:263–268
Mosad E, Elsayh KI, Eltayeb AA (2011) Tissue factor pathway inhibitor and p-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy. Clin Appl Thromb Hemost 17:80–87
Cox D, Kerrigan SW, Watson SP (2011) Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 9:1097–1107
Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O (2015) Platelets and infections—complex interactions with bacteria. Front Immunol 6:82
Eisen DP, Reid D, McBryde ES (2012) Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 40:1761–1767
de Stoppelaar SF, van 't Veer C, van der Poll T (2014) The role of platelets in sepsis. Thromb Haemost. 112.
Losche W, Boettel J, Kabisch B, Winning J, Claus RA, Bauer M (2012) Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? Thromb 2012:720254
Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M et al (2010) Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med 38:32–37
Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP et al (2009) Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 20:50–57
Tsai MJ, Ou SM, Shih CJ, Chao PW, Wang LF, Shih YN et al (2015) Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study. Intensive Care Med 41:806–813
Wiewel MA, de Stoppelaar SF, van Vught LA, Frencken JF, Hoogendijk AJ, Klein Klouwenberg PM et al (2016) Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis. Intensive Care Med 42:352–360
Antczak AJ, Singh N, Gay SR, Worth RG (2010) Igg-complex stimulated platelets: a source of scd40l and rantes in initiation of inflammatory cascade. Cell Immunol 263:129–133
Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC et al (2011) Coagulation-induced shedding of platelet glycoprotein vi mediated by factor xa. Blood 117:3912–3920
